“Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Drug Cardiotoxicity Screening”, ASCR, vol. 6, no. 1, pp. 1–6, Feb. 2023, doi: 10.5281/zenodo.22237966.